Cameron J S
Department of Nephrology and Transplantation, Guy's and St Thomas' Hospitals, King's College, London, United Kingdom.
Int Urol Nephrol. 2000;32(2):193-201. doi: 10.1023/a:1007122322571.
Recent data show that, despite a long period during which few elderly patients in end-stage renal failure received grafts, there are neither medical nor ethical grounds for avoiding kidney transplantation, at least in those aged under 70 or even 75 years of age. Units in which transplantation in older recipients is routine show a good survival of recipients, and comparable survival of grafts to those placed in younger recipients. This equality of graft survival with age arises because, although death with a functioning graft is more common in the elderly (principally from cardiovascular disease and infections, with malignant diseases becoming more important with time), graft losses from rejection are lower, and so overall outcomes are similar. Long-term patient survival is better, quality of life is improved and treatment is cheaper than in comparable elderly patients maintained on hemodialysis or chronic ambulatory peritoneal dialysis. In terms of allocation to older recipients, this success presents major practical and ethical difficulties given the shortage of cadaver organs. Data do not support the idea of 'age-matching' older or marginal kidneys to older recipients: like their younger counterparts, older recipients do better with organs from younger donors. Living donors can be used successfully even in those over 70, and elderly living donors have a place in the treatment of the elderly. The optimum immunosuppressive regimes for elderly recipients have not been determined, given their poorer immune responsiveness and lower rejection rates compared with younger individuals.
近期数据显示,尽管在很长一段时间内,很少有终末期肾衰竭老年患者接受移植,但至少在70岁甚至75岁以下的患者中,没有医学或伦理理由避免进行肾脏移植。老年受者常规进行移植的单位显示受者存活率良好,且移植肾的存活率与年轻受者相当。移植肾存活率随年龄增长而保持平等,原因在于,虽然移植肾仍在发挥功能时死亡在老年人中更为常见(主要是心血管疾病和感染,随着时间推移恶性疾病变得更加重要),但因排斥反应导致的移植肾丢失率较低,因此总体结果相似。长期患者存活率更高,生活质量得到改善,且治疗费用低于接受血液透析或持续性非卧床腹膜透析的老年患者。鉴于尸体器官短缺,在将器官分配给老年受者方面,这一成功带来了重大的实际和伦理难题。数据并不支持将年龄较大或边缘性肾脏与老年受者进行“年龄匹配”的观点:与年轻受者一样,老年受者接受年轻供者的器官效果更好。即使在70岁以上的患者中,活体供者也能成功使用,且老年活体供者在老年患者治疗中占有一席之地。鉴于老年受者的免疫反应性较差且排斥率低于年轻人,尚未确定针对他们的最佳免疫抑制方案。